We are 5-methyl-2′-deoxycytidine CAS:838-07-3 manufacturer and supplier in China, Pls send inquiry of to info@nbinno.com of visit www.nbinno.com our official website should you have any interests

Chemical Name:5-methyl-2'-deoxycytidine
Molecular Formula:C10H15N3O4
Molecular Weight:241.24400
Physical and Chemical Properties:
Melting point:217-219ºC
Boiling point:492.8ºC
Flash point:251.9ºC
Appearance:White or off-white powder
Loss on drying:≤1.0%
Packing:25 kg/drum, can also be packaged according to customer requirements
Storage:Store in a cool, ventilated place
Application:A cytidine analog and an isostere of thymidine.


Related News: INSPIRE is a global, multi-center, randomized, controlled study to assess the efficacy and safety of IV rigosertib in higher-risk MDS (HR-MDS) patients who had progressed on, failed to respond to, or relapsed after previous treatment with a hypomethylating agent (HMA) within nine cycles over the course of one year after initiation of HMA treatment.4-metil-5-viniltiazol CAS:1759-28-0 This means that the drug attributes of the drug substance will be lost in the future, and the monopoly power of some drug substances will also be lost. The preparation company will become the main person in charge of the drug. The drug preparation company will be responsible for the quality of the original excipients. It will be more cautious, some raw and auxiliary materials companies whose quality cannot be guaranteed will be gradually eliminated, and the industry concentration will be further improved.100848-70-2 The drug substance is an active product that has completed the synthetic route, and the intermediate is a product in one place in the synthetic route.25519-78-2 The use of contrast agents is different from other drugs, and it needs to be used with corresponding equipment. In recent years, China is in the growth period of imaging equipment.The Company’s immuno-regulatory product candidates include ProTmune, a pharmacologically modulated, donor cell graft that is currently being evaluated in a Phase 2 clinical trial for the prevention of graft-versus-host disease, and a myeloid-derived suppressor cell immunotherapy for promoting immune tolerance in patients with immune disorders. Fate Therapeutics is headquartered in San Diego, CA.

Related Products
Product Name
cis-3-(2-Chloro-3,3,3-trifluoroprop-1-en-1-yl)-2,2-dimethylcyclopropanecarboxylic acid View Details
4-Cloromethyl-5-methyl-1,3-dioxol-2-one View Details
2,2,2-Trichloroethyl chloroformate View Details
Polyquaternium-39 Cas:25136-75-8 manufacturer N-Acetyl-L-Hydroxyproline manufacturer Lithium Trifluoromethanesulfonate manufacturer ethyl (3S,4R)-4-amino-3-methoxypiperidine-1-carboxylate,hydrochloride manufacturer 2-[3-[Bis(1-methylethyl)amino]-1-phenylpropyl]-4-methylphenol manufacturer